Medtronic launches Resolute Integrity DES in EU
Justine Varieur Cadet | August 31, 2010 | Cardiovascular Business | Interventional Cardiology
Medtronic has launched in Europe its Resolute Integrity drug-eluting stent (DES) system for the treatment of coronary artery disease, after receiving the CE mark.

Based on the engineering of continuous sinusoid technology, the Resolute Integrity DES is coupled with the MicroTrac delivery system. The Resolute Integrity DES combines continuous sinusoid technology with elements of the original Resolute DES: the cytostatic antiproliferative drug zotarolimus and the BioLinx polymer.

Justine Varieur Cadet

Related Content

Cardiologists make history, perform first-ever transcaval TAVR for pure aortic regurgitation
Q&A: Interventional cardiologist details key breakthroughs in tricuspid valve replacement and repair
Boston Scientific recalls premixed embolic agent after two deaths
New cardiac imaging strategy could reduce ICA, PCI rates
Inter-atrial shunt in RELIEVE-HF improves symptoms in HFrEF, but not HFpEF
FDA grants new imaging tool for CTO interventions its breakthrough device designation

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business
Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Design by Adaptive Theme
Trimed Popup
Trimed Popup